C4 Therapeutics, Inc.
SPIROCYCLIC COMPOUNDS

Last updated:

Abstract:

The present invention provides compounds and intermediates. The present invention also provides compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and their use for the treatment of abnormal cellular proliferation. The present invention also provides compounds that may be used as synthetic intermediates in the synthesis of bifunctional compounds used for targeted protein degradation.

Status:
Application
Type:

Utility

Filling date:

24 Nov 2020

Issue date:

11 Mar 2021